References 1. Bell DG, Jacobs I, Ellerington K: Effect of AZD3965 caffeine and ephedrine MAPK inhibitor ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001, 33:1399–1403.PubMedCrossRef 2. Doherty M: The effects of caffeine on the maximal accumulatd oxygen deficit and short-term running performance. Int J Sport Nutr 1998, 8:95–104.PubMed 3. Doherty M, Smith PM, Davison RC, Hughes MG: Caffeine is ergogenic after supplementation of oral creatine monohydrate. Med Sci Sports Exerc
2002, 34:1785–1792.PubMedCrossRef 4. Cox GR, Desbrow B, Montgomery PG, Anderson ME, Bruce CR, Macrides TA, Martin DT, Moquin A, Roberts A, Hawley JA, Burke LM: Effect of different protocols of caffeine intake on metabolism and endurance performance. J Appl Physiol 2002, 93:990–999.PubMed 5. Denadai BS, Denadai ML: Effects of caffeine on time to exhaustion in exercise performed below and above
the anaerobic threshold. Braz J Med Biol Res 1998, 31:581–585.PubMedCrossRef 6. Meyers BM, Cafarelli E: Caffeine increases time to fatigue by maintaining force and not FDA-approved Drug Library by altering firing rates during submaximal isometric contractions. J Appl Physiol 2005, 99:1056–1063.PubMedCrossRef 7. Beck TW, Housh TJ, Malek MH, Mielke M, Hendrix R: The acute effects of a caffeine-containing supplement on bench press strength and time to running exhaustion. J Strength Cond Res 2008, 22:1654–1658.PubMedCrossRef 8. Jacobson TL, Febbraio MA, Arkinstall MJ, Hawley JA: Effect of caffeine co-ingested with carbohydrate or fat on metabolism and performance in endurance-trained men. Exp Physiol 2001, 86:137–144.PubMedCrossRef 9. Williams JH, Signorile JF, Barnes
WS, Henrich TW: Caffeine, maximal power output and fatigue. Br J Sports Med 1988, 22:132–134.PubMedCrossRef 10. Sachse C, Brockmoller J, Bauer S, Roots I: Functional significance of a C- > A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999, 47:445–449.PubMedCrossRef 11. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H: Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006, 295:1135–1141.PubMedCrossRef 12. Cornelis MC, El-Sohemy A, Campos H: Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Med Genet 2004, 41:758–762.PubMedCrossRef 13. Hallstrom H, Melhus H, Glynn A, Lind L, Syvanen AC, Michaelsson pentoxifylline K: Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study. NutrMetab 2010, 7:12–20. 14. Mayo Clinic. How much caffeine is in your daily habit? [http://www.mayoclinic.com/health/caffeine/AN01211] 15. Grosso LM, Bracken MB: Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 2005, 15:460–466.PubMedCrossRef 16. Daly JW, Butts-Lamb P, Padgett W: Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.